Basic Information
ID: ALA5099263
Type: Functional
Description: Agonist activity at human adenosine A2A receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation by measuring maximal efficacy incubated for 30 mins by LANCE ultra assay relative to control
Organism: Homo sapiens
Cell type: CHO-K1
Activity Charts
Bioactivity
Activity Types for Assay ALA5099263
Emax
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 267.25 | -1.98 | -1.98 |
| 308.30 | -1.84 | -1.84 |
| 441.49 | 0.99 | 0.99 |
| 468.51 | 0.99 | 0.99 |
| 502.96 | 1.65 | 1.65 |
| 516.99 | 1.78 | 1.78 |
| 461.91 | 1.50 | 1.50 |
| 498.54 | 1.00 | 1.00 |
| 524.62 | 2.29 | 2.29 |
| 502.96 | 1.65 | 1.65 |
| 502.96 | 1.65 | 1.65 |
| 461.91 | 1.50 | 1.50 |
| 475.93 | 1.64 | 1.64 |
| 457.49 | 0.86 | 0.86 |
| 547.41 | 1.76 | 1.76 |
| 461.91 | 1.50 | 1.50 |
| 516.99 | 1.78 | 1.78 |